ENDRA Life Sciences Inc. — Director's Dealing 2017

Jun 28, 2017

SEC Form 3/A — Form 3/A

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2017-05-08

Reporting Person: Tokman Alexander Y (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$10.01	2021-01-01	Common Stock (1799)		Direct

Footnotes

F1: These Stock Options were omitted from the reporting person's original Form 3.